Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Manufacturing

Promega opens new Shanghai facility

Read more
Provides additional r&d and cGMP manufacturing capabilities

Trending Articles

  1. From data to decisions: applying criticality and failure probability in process risk mitigation This article presents an exploration of how structured, data-based methods enhance quality control, optimise specifications and improve process robustness throughout the product lifecycle
  2. Marchesini Group and AST announce strategic partnership to strengthen aseptic production capacity and expand global market presence Marchesini Group, a leader in pharmaceutical packaging machinery, and AST, a US leader in the drug product manufacturing industry, have entered a strategic partnership that combines the expertise, technologies, and global reach of two highly respected industry leaders
  3. Manufacturing Chemist Stand Side with GEA and Hovione We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  4. A-Z Color advances automated quality control in pharmaceutical label production EyeC inspection systems help deliver zero-error labels and GMP-compliant reliability
  5. Irish CDMOs Gaelic Labs and Athlone merge to expand penicillin manufacturing capacity Gaelics acquisition of the leading developer and manufacturer of oral dose Beta-Lactams will strengthen its market position and enhance the company's manufacturing capabilities

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Manufacturing

Cellevate achieves ISO 9001:2015 certification alongside GMP production processes in new cleanroom

The certification caps off a strong 2025 for the company, which now has a scalable foundation for expanding manufacturing capacity and implementing GMP-ready processes for commercial volumes
Manufacturing

LYOVAC® ECO Mode: making pharmaceutical freeze-drying leaner and greener

Following the recent announcement that GEA Lyophil has received third-party certification for the energy-saving credentials of its innovative algorithm for freeze-drying applications, Dr Kevin Robinson caught up with Senior Director of Lyophilization Technology Management, Thomas Beutler, to find out more
Manufacturing

IMA Active launches new tablet press range in stunning film location

The Italy-based pharmaceutical equipment company has launched its innovative new DOMINA AND SOLIDA at Villa Erba on Lake Como, which has historic ties to the pharmaceutical industry
Manufacturing

Particology joins £8.2m consortium to drive greener, more efficient medicines manufacturing

The company has been selected for Innovate UK’s £54m Sustainable Medicines Manufacturing Innovation Programme, leading crystallisation research to cut waste, reduce energy use and accelerate next-generation pharmaceutical production
Manufacturing

Valve diagnostics: providing new insights for medical and lab applications

Across a range of medical and laboratory applications, confirmation of liquid flow status is critical, but integrating sensors or electronics to check the performance of functions like valve switching adds design complexity
Manufacturing

Marchesini Group and AST announce strategic partnership to strengthen aseptic production capacity and expand global market presence

Marchesini Group, a leader in pharmaceutical packaging machinery, and AST, a US leader in the drug product manufacturing industry, have entered a strategic partnership that combines the expertise, technologies, and global reach of two highly respected industry leaders
Subscribe now